BioLife Solutions, Inc. (BLFS)
NASDAQ: BLFS · Real-Time Price · USD
19.90
+0.04 (0.20%)
At close: Mar 9, 2026, 4:00 PM EDT
19.90
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:02 PM EDT
BioLife Solutions Revenue
In the year 2025, BioLife Solutions had annual revenue of $96.21M with 28.89% growth. BioLife Solutions had revenue of $24.76M in the quarter ending December 31, 2025, with 63.91% growth.
Revenue (ttm)
$96.21M
Revenue Growth
+28.89%
P/S Ratio
9.72
Revenue / Employee
$620,735
Employees
155
Market Cap
960.20M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 96.21M | 21.57M | 28.89% |
| Dec 31, 2024 | 74.65M | 6.63M | 9.75% |
| Dec 31, 2023 | 68.02M | -8.22M | -10.79% |
| Dec 31, 2022 | 76.24M | -42.92M | -36.02% |
| Dec 31, 2021 | 119.16M | 71.07M | 147.79% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DENTSPLY SIRONA | 3.68B |
| Embecta | 1.08B |
| Azenta | 595.03M |
| AtriCure | 534.53M |
| AngioDynamics | 307.31M |
| LeMaitre Vascular | 249.60M |
| STAAR Surgical Company | 239.44M |
| Kestra Medical Technologies | 74.26M |
BLFS News
- 3 days ago - BioLife Looks Strong For Fiscal Year 2026 - Seeking Alpha
- 10 days ago - BioLife Solutions, Inc. (BLFS) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 11 days ago - BioLife Solutions Reports Fourth Quarter and Full Year 2025 Financial Results from Continuing Operations - PRNewsWire
- 20 days ago - BioLife Solutions to Report Fourth Quarter and Full Year 2025 Financial Results and Business Update on February 26, 2026 - PRNewsWire
- 25 days ago - BioLife Solutions Signs Multi-Year Supply Agreement with Qkine Limited to Expand its Product Portfolio into the Rapidly Growing Cytokines Market - PRNewsWire
- 2 months ago - BioLife Solutions Announces Preliminary Fourth Quarter and Full Year 2025 Unaudited Revenue from Continuing Operations - PRNewsWire
- 3 months ago - BioLife Solutions Unveils the Aby J. Mathew Center for Biopreservation Excellence - PRNewsWire
- 4 months ago - BioLife Solutions to Participate in Upcoming Investor Conferences in November and December 2025 - PRNewsWire